We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

38 hedge funds and large institutions have $268M invested in Sierra Oncology, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
1.06%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$127M
2
O
OrbiMed
New York
+$56.1M
3
DM
Deerfield Management
New York
+$38M
4
ASP
Adams Street Partners
Illinois
+$32.7M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$24.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$92.5M +$127M +112,718 New
O
2
OrbiMed
New York
$40.8M +$56.1M +49,749 New
DM
3
Deerfield Management
New York
$27.7M +$38M +33,710 New
ASP
4
Adams Street Partners
Illinois
$17.8M +$32.7M +28,989 New
SAM
5
Sectoral Asset Management
Quebec, Canada
$17.3M +$24.3M +21,569 New
RIM
6
RS Investment Management
California
$12.8M +$17.6M +15,581 New
RCM
7
RA Capital Management
Massachusetts
$12.4M +$17.1M +15,125 New
HCM
8
Hayman Capital Management
Texas
$8.66M +$11.9M +10,555 New
Franklin Resources
9
Franklin Resources
California
$5.13M +$7.05M +6,253 New
VM
10
VHCP Management
New York
$5.13M +$7.05M +6,250 New
BBA
11
Baker Bros. Advisors
New York
$4.1M +$5.64M +5,000 New
Jennison Associates
12
Jennison Associates
New York
$3.09M +$4.24M +3,760 New
Federated Hermes
13
Federated Hermes
Pennsylvania
$3.08M +$4.23M +3,750 New
Millennium Management
14
Millennium Management
New York
$2.28M +$3.13M +2,774 New
GT
15
Greenleaf Trust
Michigan
$1.99M +$2.73M +2,425 New
LOAMU
16
Lombard Odier Asset Management (USA)
New York
$1.91M +$2.62M +2,322 New
Morgan Stanley
17
Morgan Stanley
New York
$1.8M +$2.47M +2,190 New
BA
18
BlackRock Advisors
Delaware
$1.67M +$2.3M +2,038 New
CS
19
Candriam SCA
Luxembourg
$1.46M +$2.01M +1,780 New
PAMU
20
Pictet Asset Management (UK)
United Kingdom
$1.33M +$1.82M +1,618 New
CAM
21
Cormorant Asset Management
Massachusetts
$1.09M +$1.5M +1,329 New
CC
22
Caxton Corporation
New Jersey
$938K +$1.29M +1,143 New
CS
23
Credit Suisse
Switzerland
$476K +$654K +580 New
RG
24
Redmile Group
California
$377K +$519K +460 New
Goldman Sachs
25
Goldman Sachs
New York
$354K +$487K +432 New
1
2

SRRA Hedge Fund Activity: Q3 2015 in Review

38 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q3 2015, worth a combined $268M.

Buyers outnumbered sellers: 38 funds opened new SRRA positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $127M.

  • 38 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q3 2015, up from 0 in Q2 2015.
  • Funds reported $268M of Sierra Oncology, Inc. Common Stock stock for Q3 2015.
  • 38 funds opened new Sierra Oncology, Inc. Common Stock positions in Q3 2015 and 0 closed out, a net change of +38 holders.
  • The largest Sierra Oncology, Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $127M added.

Based on aggregated 13F filings for Q3 2015.